Hologic (HOLX)
(Delayed Data from NSDQ)
$75.38 USD
+0.28 (0.37%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $75.37 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Hologic (HOLX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$84.36 | $95.00 | $72.00 | 12.33% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Hologic comes to $84.36. The forecasts range from a low of $72.00 to a high of $95.00. The average price target represents an increase of 12.33% from the last closing price of $75.10.
Analyst Price Targets (11)
Broker Rating
Hologic currently has an average brokerage recommendation (ABR) of 2.08 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 2.23 a month ago based on 13 recommendations.
Of the 13 recommendations deriving the current ABR, five are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 38.46% and 15.38% of all recommendations. A month ago, Strong Buy made up 30.77%, while Buy represented 15.38%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 4 | 4 | 4 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 6 | 6 | 7 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.08 | 2.08 | 2.23 | 2.23 | 2.23 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/12/2024 | SVB Securities | Puneet Souda | Strong Buy | Strong Buy |
4/10/2024 | Needham & Company | Michael Matson | Moderate Buy | Moderate Buy |
4/4/2024 | Evercore Partners | Vijay Kumar | Hold | Hold |
2/2/2024 | Raymond James | Andrew Cooper | Moderate Buy | Moderate Buy |
1/8/2024 | William Blair | Andrew F Brackmann | Strong Buy | Strong Buy |
1/7/2024 | BTIG | Ryan Zimmerman | Hold | Hold |
10/17/2023 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.08 |
ABR (Last week) | 2.08 |
# of Recs in ABR | 13 |
Average Target Price | $84.36 |
LT Growth Rate | 7.40% |
Industry | Medical - Instruments |
Industry Rank by ABR | 96 of 252 |
Current Quarter EPS Est: | 0.97 |